Literature DB >> 27188838

Design, synthesis and in vitro splicing inhibition of desmethyl and carba-derivatives of herboxidiene.

Arun K Ghosh1, Kai Lv, Nianchun Ma, Emilio L Cárdenas, Kerstin A Effenberger, Melissa S Jurica.   

Abstract

Herboxidiene is a potent inhibitor of spliceosomes. It exhibits excellent anticancer activity against multiple human cancer cell lines. Herein, we describe an enantioselective synthesis of a desmethyl derivative and the corresponding carba-derivatives of herboxidiene. The synthesis involved Suzuki coupling of a vinyl iodide with boronate as the key reaction. For the synthesis of carba-derivatives, the corresponding optically active cyclohexane-1,3-dicarbonyl derivatives were synthesized using an enantioselective desymmetrization of meso-anhydride. The biological properties of these derivatives were evaluated in an in vitro splicing assay.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27188838      PMCID: PMC5333946          DOI: 10.1039/c6ob00725b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  31 in total

1.  Rhodium-catalyzed enantioselective desymmetrization of meso-3,5-dimethyl glutaric anhydride: a general strategy to syn-deoxypolypropionate synthons.

Authors:  Matthew J Cook; Tomislav Rovis
Journal:  J Am Chem Soc       Date:  2007-07-10       Impact factor: 15.419

2.  Targeting the spliceosome.

Authors:  Brian Rymond
Journal:  Nat Chem Biol       Date:  2007-09       Impact factor: 15.040

3.  A stereoselective synthesis of (+)-herboxidiene/GEX1A.

Authors:  Arun K Ghosh; Jianfeng Li
Journal:  Org Lett       Date:  2010-12-02       Impact factor: 6.005

Review 4.  Aberrant and alternative splicing in cancer.

Authors:  Julian P Venables
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

Review 5.  The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.

Authors:  Thomas R Webb; Amanda S Joyner; Philip M Potter
Journal:  Drug Discov Today       Date:  2012-08-03       Impact factor: 7.851

6.  Splicing factor SF3b as a target of the antitumor natural product pladienolide.

Authors:  Yoshihiko Kotake; Koji Sagane; Takashi Owa; Yuko Mimori-Kiyosue; Hajime Shimizu; Mai Uesugi; Yasushi Ishihama; Masao Iwata; Yoshiharu Mizui
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

7.  Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs.

Authors:  Kerstin A Effenberger; David D Anderson; Walter M Bray; Beth E Prichard; Nianchun Ma; Matthew S Adams; Arun K Ghosh; Melissa S Jurica
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

8.  Pre-mRNA splicing-modulatory pharmacophores: the total synthesis of herboxidiene, a pladienolide-herboxidiene hybrid analog and related derivatives.

Authors:  Chandraiah Lagisetti; Maria V Yermolina; Lalit Kumar Sharma; Gustavo Palacios; Brett J Prigaro; Thomas R Webb
Journal:  ACS Chem Biol       Date:  2013-12-30       Impact factor: 5.100

Review 9.  Genomic variants in exons and introns: identifying the splicing spoilers.

Authors:  Franco Pagani; Francisco E Baralle
Journal:  Nat Rev Genet       Date:  2004-05       Impact factor: 53.242

Review 10.  The spliceosome as target for anticancer treatment.

Authors:  R J van Alphen; E A C Wiemer; H Burger; F A L M Eskens
Journal:  Br J Cancer       Date:  2008-11-25       Impact factor: 7.640

View more
  6 in total

Review 1.  Therapeutic approaches to treat human spliceosomal diseases.

Authors:  Anthony B DeNicola; Yi Tang
Journal:  Curr Opin Biotechnol       Date:  2019-02-15       Impact factor: 9.740

2.  Re2 O7 -Mediated Dehydrative Cyclization Reactions: Total Synthesis of Herboxidiene and Its 12-Desmethyl Analogue.

Authors:  Tyler M Rohrs; Qi Qin; Paul E Floreancig
Journal:  Angew Chem Int Ed Engl       Date:  2017-07-28       Impact factor: 15.336

3.  Enantioselective Synthesis of Thailanstatin A Methyl Ester and Evaluation of in Vitro Splicing Inhibition.

Authors:  Arun K Ghosh; Anne M Veitschegger; Shenyou Nie; Nicola Relitti; Andrew J MacRae; Melissa S Jurica
Journal:  J Org Chem       Date:  2018-04-26       Impact factor: 4.354

4.  Design and synthesis of herboxidiene derivatives that potently inhibit in vitro splicing.

Authors:  Arun K Ghosh; Srinivasa Rao Allu; Guddeti Chandrashekar Reddy; Adriana Gamboa Lopez; Patricia Mendez; Melissa S Jurica
Journal:  Org Biomol Chem       Date:  2021-02-18       Impact factor: 3.876

Review 5.  Alternative Splicing as a Target for Cancer Treatment.

Authors:  Nancy Martinez-Montiel; Nora Hilda Rosas-Murrieta; Maricruz Anaya Ruiz; Eduardo Monjaraz-Guzman; Rebeca Martinez-Contreras
Journal:  Int J Mol Sci       Date:  2018-02-11       Impact factor: 5.923

6.  Herboxidiene Features That Mediate Conformation-Dependent SF3B1 Interactions to Inhibit Splicing.

Authors:  Adriana Gamboa Lopez; Srinivasa Rao Allu; Patricia Mendez; Guddeti Chandrashekar Reddy; Hannah M Maul-Newby; Arun K Ghosh; Melissa S Jurica
Journal:  ACS Chem Biol       Date:  2021-02-22       Impact factor: 5.100

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.